Firefly Neuroscience, Inc.
PublicFirefly Neuroscience, Inc. is now publicly traded
The data on this page reflects Firefly Neuroscience, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Mar 13, 2026
Total Funding Raised
$2.25M
Company Overview
Firefly Neuroscience, Inc. is a medical technology and AI company that provides an FDA-cleared Brain Network Analytics (BNA™) software platform to improve outcomes for patients with mental illnesses and neurological disorders.
AI Layer
Application
Keywords
Brain Network AnalyticsBNAEEG analysisAI diagnosticsdigital biomarkerprecision psychiatryneurotechFDA-cleared platformqEEGquantitative EEGmental health techERP analysisobjective diagnosticsneurodiagnostic devicebrain mappingclinical trial support
Firefly Neuroscience, Inc. Comparables
Compare Firefly Neuroscience, Inc. with similar companies based on industry and business-model similarity.
Firefly Neuroscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Mar 13, 2026 |
Key People
Founding team and executive leadership
Firefly Neuroscience, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersKenmore
Employee Range25
Year Founded2006
Last FundingMar 13, 2026